Riley George, Scheyer Nicolas, Klein Marc, Merlot Isabelle, Guerci Bruno, Jeanbert Elodie, Demarquet Lea
Endocrinology, Diabetes and Nutrition, Centre Hospitalier Universitaire de Nancy, Nancy, France.
Neurosurgery, Centre Hospitalier Universitaire de Nancy, Nancy, France.
Front Endocrinol (Lausanne). 2024 Jan 11;14:1327404. doi: 10.3389/fendo.2023.1327404. eCollection 2023.
The primary aim of this study was to identify predictive factors associated with onset of clinically significant pituitary insufficiencies following endoscopic endonasal surgery (EES) for pituitary adenomas. The secondary objective explored the predictive factors of surgical success.
A retrospective analysis was conducted on 211 patients who underwent EES. Logistic regression models were employed for the primary and secondary objectives. Patients were stratified into specific groups based on surgical indications and prolactin levels for nuanced analysis.
Significant predictors for pituitary insufficiencies included male sex (OR 3.3, CI95% 1.3-8.1, p=0.01), immediate postoperative insufficiencies (OR 5.6, CI95% 2.8-11.1, p<0.001), and HYPRONOS criteria (OR 5.7, CI95% 1.6-20.9, p=0.008). For surgical success, preoperative insufficiencies (OR 0.7, CI95% 0.5-0.9, p=0.008), repeat surgeries (OR 0.1, CI95% 0-0.4, p=0.001), and gonadotroph or somatotroph adenomas were significant. Age and adenoma size were not predictive in multivariate analysis. Furthermore, we observed a "dip and recover" effect of prolactin after surgery and lower prolactin levels at follow-up (< 3 ng/ml) are correlated with more anterior pituitary insufficiencies than normoprolactinemic patients (p = 0.004).
This study identifies key predictors for outcomes in pituitary surgery. Our research is the first to employ individualized success criteria for EES, challenging existing perceptions about the role of age and adenoma size. These findings open avenues for nuanced, individualized preoperative risk assessment and postoperative management.
本研究的主要目的是确定垂体腺瘤经鼻内镜手术(EES)后发生具有临床意义的垂体功能减退的相关预测因素。次要目的是探究手术成功的预测因素。
对211例行EES的患者进行回顾性分析。采用逻辑回归模型实现主要和次要目的。根据手术指征和催乳素水平将患者分层为特定组进行细致分析。
垂体功能减退的显著预测因素包括男性(比值比3.3,95%置信区间1.3 - 8.1,p = 0.01)、术后即刻功能减退(比值比5.6,95%置信区间2.8 - 11.1,p < 0.001)以及HYPRONOS标准(比值比5.7,95%置信区间1.6 - 20.9,p = 0.008)。对于手术成功,术前功能减退(比值比0.7,95%置信区间0.5 - 0.9,p = 0.008)、再次手术(比值比0.1,95%置信区间0 - 0.4,p = 0.001)以及促性腺激素瘤或生长激素瘤具有显著意义。年龄和腺瘤大小在多因素分析中无预测价值。此外,我们观察到术后催乳素的“下降并恢复”效应,且随访时催乳素水平较低(< 3 ng/ml)的患者比催乳素水平正常的患者发生更多垂体前叶功能减退(p = 0.004)。
本研究确定了垂体手术结局的关键预测因素。我们的研究首次采用EES个体化成功标准,挑战了关于年龄和腺瘤大小作用的现有观念。这些发现为细致的个体化术前风险评估和术后管理开辟了道路。